AhlgrenJ., LokichJ., FryerJ.G., FryerD., ConlanJ.C., CapizziR.L., ScheinP.: Phase III randomized trial of protracted venous infusion (PVI) fluorouracil with or without weekly bolus PALA in advanced colon cancer.Proc. Am. Soc. Clin. Oncol., (Abst) 1996.
2.
HansenR.M., RyanL., AndersonT., KrzywdaB., QuebbemanE., BensonA3rd, HallerD.G., TormeyD.C.: Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.J. Nat. Canc. Instit.,88: 668–674, 1996.
3.
HillM., NormanA., CunninghamD., FindlayM., WatsonM., NicolsonV., WebbA., MiddletonG., AhmedF., HickishT.: Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response survival and quality of life in advanced colorectal cancer.J. Clin. Oncol., 13: 2317–2323, 1995.
4.
LeichmanC.G., FlemingT.R., MuggiaF.M., TangenC.M., ArdalanB., DoroshowJ.H., MeyersF.J., HolcombeR.F., WeissG.R., MangalikA.: Phase II study of fluorouracil and its modulation in advanced colorectal cancer. A Southwest Oncology Group Study.J. Clin. Oncol., 13: 1303–1311, 1995.
5.
LokichJ.: Infusional 5-fluorouracil for colorectal cancer: literature review and present status.J. Infus. Chemo., 3: 119–124, 1993.
LokichJ.J., AhlgrenJ.D., CantrellJ., HeimW.J., WamplerG.L., GulloJ.J., FryerJ.G., AltD.: A prospective randomized comparison of protracted infusion 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid Atlantic Oncology Program Study.Cancer, 67: 14–19, 1991.
8.
LokichJ.J., AhlgrenJ.D., GulloJ.J., PhilipsJ.A., FryerJ.: A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma.J. Clin. Oncol., 425–432, 1989.
9.
PazdurR., LassereY., RhodesV., AjaniJ.A., SugarmanS.M., PattY.Z., JonesD.V.Jr., MarkowitzA.B., AbbruzzeseJ.L., BreadyB.: Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.J. Clin. Oncol., 12: 2296–2300, 1994.
10.
PiedboisP.: Personal communication.
11.
RougierP.H., PaillotB., LaplancheA., MorvanF., BenhameD.M., SeitzJ.L., LaplaigePh., JacobJ., GrandjovanS., Netter PinonG., KamionerD., CombesM., FabriM.C., LuboinskiM., TigaudJ.M.: End results of a multicentric randomized trial comparing 5FU in continuous systemic infusion (CI) to bolus administration (B) in measurable colorectal cancer (MCC).Proc. Am. Soc. Clin. Oncol.,11(Abst), 1992.
12.
SeifertP., BakerL.H., ReedM.D., VaitkeviciusV.K.: Comparison of continuously infused 5-fluorouracil with bolus injection in patients with colorectal adenocarcinoma.Cancer, 36: 123–128, 1975.
13.
WeinermanB., ShahA., FieldsA.: Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancer.Am. J. Clin. Oncol., 15: 518–523, 1992.
